Rachel S. Flynn, Morgan E. Hill, Julia E. Rood & Joanna J. Parga. (2020) Abnormal Eye Movements and Poor Feeding in an Infant. Clinical Pediatrics 59:4-5, pages 532-535.
Crossref
Laura P. McLafferty, Madeleine Becker, Nehama Dresner, Samantha Meltzer-Brody, Priya Gopalan, Jody Glance, Guitelle St. Victor, Leena Mittal, Patrick Marshalek, Laura Lander & Linda L.M. Worley. (2016) Guidelines for the Management of Pregnant Women With Substance Use Disorders. Psychosomatics 57:2, pages 115-130.
Crossref
Sachin K. Gupta, Pam Haerr, Richard David, Alok Rastogi & Suma Pyati. (2016) Meconium aspiration syndrome in infants of HIV-positive women: a case-control study. Journal of Perinatal Medicine 44:4.
Crossref
Emily Smith, Ihab Kamel & Dimitrios S. Mastrogiannis. (2014) Drug Addiction and Pregnancy. Postgraduate Obstetrics & Gynecology 34:22, pages 1-7.
Crossref
Sabrina D. Diaz & Lynne M. Smith. 2012. Handbook of Growth and Growth Monitoring in Health and Disease. Handbook of Growth and Growth Monitoring in Health and Disease
235
261
.
J.J. Hubbard, E.M. Laurenzana, D.K. Williams, W.B. Gentry & S.M. Owens. (2011) Chronic anti-phencyclidine monoclonal antibody therapy decreases phencyclidine-induced in utero fetal mortality in pregnant rats. International Immunopharmacology 11:12, pages 2181-2187.
Crossref
Louis A. Pagliaro & Ann Marie Pagliaro. 2011. Handbook of Child and Adolescent Drug and Substance Abuse. Handbook of Child and Adolescent Drug and Substance Abuse
371
453
.
Neil S. Seligman. 2011. Maternal-Fetal Evidence Based Guidelines. Maternal-Fetal Evidence Based Guidelines
161
176
.
Karen J. Farst, Jimmie L. Valentine & R. Whit Hall. (2011) Drug Testing for Newborn Exposure to Illicit Substances in Pregnancy: Pitfalls and Pearls. International Journal of Pediatrics 2011, pages 1-7.
Crossref
Hsiao-Lin Hwa. (2010) Intrauterine Illicit Substance Exposure. Pediatrics & Neonatology 51:5, pages 253-254.
Crossref
John C.M. Brust. 2009. Clinical Neurotoxicology. Clinical Neurotoxicology
314
328
.
Christine M. Moore. 2008. Drug Testing in Alternate Biological Specimens. Drug Testing in Alternate Biological Specimens
19
41
.
John C.M. Brust. 2007. Aspects neurologiques de l'addiction. Aspects neurologiques de l'addiction
357
374
.
Stephen R. Carr & Donald R. Coustan. 2007. Clinical Obstetrics. Clinical Obstetrics
236
247
.
Joey Gareri, Julia Klein & Gideon Koren. (2006) Drugs of abuse testing in meconium. Clinica Chimica Acta 366:1-2, pages 101-111.
Crossref
Kenneth Burgdorf, Kathleen Dowell, Xiaowu Chen, Tracy Roberts & James M Herrell. (2004) Birth outcomes for pregnant women in residential substance abuse treatment. Evaluation and Program Planning 27:2, pages 199-204.
Crossref
John C.M. Brust. 2004. Neurological Aspects of Substance Abuse. Neurological Aspects of Substance Abuse
293
307
.
Nancy Kenepp & Ashwin Chatwani. 2004. Anesthetic and Obstetric Management of High-Risk Pregnancy. Anesthetic and Obstetric Management of High-Risk Pregnancy
403
431
.
Keeta DeStefano Lewis & Sandra J Weiss. (2003) Psychometric testing of an infant risk assessment for prenatal drug exposure. Journal of Pediatric Nursing 18:6, pages 371-378.
Crossref
Fonda Davis Eyler, Marylou Behnke, Cynthia Wilson Garvan, Nanci Stewart Woods, Kathleen Wobie & Michael Conlon. (2001) Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure. Neurotoxicology and Teratology 23:5, pages 399-411.
Crossref
Marc A. SchuckitMarc A. Schuckit. 2000. Drug and Alcohol Abuse. Drug and Alcohol Abuse
210
220
.
Embry M. Howell, Nancy Heiser & Mary Harrington. (1999) A Review of Recent Findings on Substance Abuse Treatment for Pregnant Women. Journal of Substance Abuse Treatment 16:3, pages 195-219.
Crossref
Karen D'Apolito. (1998) Substance abuse: infant and childhood outcomes. Journal of Pediatric Nursing 13:5, pages 307-316.
Crossref
Karen F. Buchi. (1998) The Drug-Exposed Infant in the Well-Baby Nursery. Clinics in Perinatology 25:2, pages 335-350.
Crossref
M PAULE. 1998. Handbook of Developmental Neurotoxicology. Handbook of Developmental Neurotoxicology
617
629
.
Merith Cosden, Stacey Peerson & Katherine Elliott. (1997) Effects of Prenatal Drug Exposure on Birth Outcomes and Early Child Development. Journal of Drug Issues 27:3, pages 525-539.
Crossref
Barry M. Lester, Lyn LaGasse & Susan Brunner. (1997) Data Base of Studies on Prenatal Cocaine Exposure and Child Outcome. Journal of Drug Issues 27:3, pages 487-499.
Crossref
Michael D. Stein & Michele G. Cyr. (1997) WOMEN AND SUBSTANCE ABUSE. Medical Clinics of North America 81:4, pages 979-998.
Crossref
Jeanne M. Johnson, J.Anthony Seikel, Charles L. Madison, Shari M. Foose & Keri D. Rinard. (1997) Standardized test performance of children with a history of prenatal exposure to multiple drugs/cocaine. Journal of Communication Disorders 30:1, pages 45-73.
Crossref
Christine M. MooreDouglas E. LewisJerrold B. Leikin. (1996) The Determination of Phencyclidine in Meconium Using Ion Trap Mass Spectrometry. Journal of Forensic Sciences 41:6, pages 14049J.
Crossref
MARGARET E. SPRAUVEMD, MPHMD, MPH. (1996) Substance Abuse and HIV in Pregnancy. Clinical Obstetrics and Gynecology 39:2, pages 316-332.
Crossref
R. L. Balster & J. Willetts. 1996. Pharmacological Aspects of Drug Dependence. Pharmacological Aspects of Drug Dependence
233
262
.
Linda M. Peterson, William J. Bums & Susan M. Wiidmayer. (1995) Developmental risk for infants of maternal cocaine abusers: Evaluation and critique. Clinical Psychology Review 15:8, pages 739-776.
Crossref
Marc A. SchuckitMarc A. Schuckit. 1995. Drug and Alcohol Abuse. Drug and Alcohol Abuse
206
216
.
. (1993) Effects of in utero exposure to street drugs.. American Journal of Public Health 83:Suppl, pages 1-32.
Crossref
Frank M. Scalzo & Lora J. Burge. (1992) The ontogeny of phencyclidine-induced wall climbing and locomotor activity. Developmental Psychobiology 25:8, pages 597-612.
Crossref